Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

3 Nov 2010 07:00

RNS Number : 5103V
Halma PLC
03 November 2010
 



Halma p.l.c. ('Halma')

 

ACQUISITION OF ALICAT SCIENTIFIC

 

 

Halma, the leading safety, health and sensor technology group, announces the acquisition of Alicat Scientific, Incorporated ('Alicat') from financial shareholders and members of current management for a cash consideration of $25.2 million (£15.7 million), paid at completion on 2 November 2010.

 

Alicat, a privately-owned business in Tucson, Arizona, USA designs and manufactures mass flow meters and controllers which are used in life science and industrial applications for high-precision measurement of fluid flows. Alicat will join Halma's Health and Analysis sector within the Fluid Technology group of businesses.

 

Unaudited accounts for the financial year ended September 2010 show operating profit of $3.2 million (£2.0 million). The cash consideration is adjustable $1 for $1 if the completion accounts demonstrate net tangible assets above or below $1.5 million (£0.9 million). The acquisition, which is immediately earnings enhancing, has been funded from Halma's existing cash and debt facilities.

 

Andrew Williams, Halma's Chief Executive, commented:

"Alicat adds new technologies and end market applications to our Fluid Technology businesses which currently focus on fluid flow via precision miniature tubing assemblies, connectors and valves. This acquisition provides new cross- selling opportunities and the Halma hubs in Asia will help Alicat accelerate their recent sales growth in that important region."

 

 

For further information please contact:

 

Halma p.l.c.

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 7357 9477

 

Notes

1.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com.

2.

This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma.

3.

Exchange rate used: $1.605/£1.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBTBPTMBAMBRM
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.